Trial Profile
Efficacy of canagliflozin versus liraglutide, alternative to bolus insulin in patients with basal-bolus regimen.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2018
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary) ; Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ECLIPS
- 29 Oct 2018 Status changed from active, no longer recruiting to completed.
- 05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes
- 29 Nov 2017 Status changed from recruiting to active, no longer recruiting.